Literature DB >> 10421784

Antigen presentation function of brain-derived dendriform cells depends on astrocyte help.

H G Fischer1, A K Bielinsky.   

Abstract

In mouse brain primary culture, supplementation with granulocyte macrophage colony-stimulating factor (GM-CSF) induces development of dendriform cells emerging on the astroglia monolayer. As revealed by flow cytofluorimetric analysis, >70% of isolated cells are CD11c(+) and express the dendritic cell (DC) marker 33D1. Additional expression of F4/80 and CD11b suggests a myeloid origin of these cells. The lymphoid DC marker CD8alpha is lacking while DEC-205 has been detected on approximately 10% of the cells. When freshly isolated, such brain-derived DC-like cells are excellent antigen-presenting cells (APC) but their functional capability is lost during subculture with GM-CSF. In contrast, their antigen presentation function remains stable in the presence of GM-CSF plus astrocytes or astrocyte-conditioned medium. The responsible astrocytic activity co-fractionates with macrophage colony-stimulating factor (M-CSF). Neutralization of the activity with anti-M-CSF antibody and substitution with recombinant M-CSF provide evidence that, in addition to GM-CSF, M-CSF is required to preserve the functional capability of these brain-derived APC. Responsiveness of the isolated cells to M-CSF is substantiated by the expression of c-fms/M-CSF receptor gene. Consistently, GM-CSF proves stimulatory for astrocytes by up-regulating their secretion of M-CSF. Furthermore, depletion or blocking of endogenous M-CSF in primary brain cell culture prevents the development of functionally active APC regardless of exogenous GM-CSF. In sum, these findings ascribe an immature DC phenotype to GM-CSF-grown myeloid brain cells and indicate a role for astrocytic M-CSF in maintaining their antigen presentation function.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10421784     DOI: 10.1093/intimm/11.8.1265

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  10 in total

1.  Developmental plasticity of CNS microglia.

Authors:  L Santambrogio; S L Belyanskaya; F R Fischer; B Cipriani; C F Brosnan; P Ricciardi-Castagnoli; L J Stern; J L Strominger; R Riese
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-22       Impact factor: 11.205

2.  Elevated expression of CCR5 by myeloid (CD11c+) blood dendritic cells in multiple sclerosis and acute optic neuritis.

Authors:  M Pashenkov; N Teleshova; M Kouwenhoven; V Kostulas; Y-M Huang; M Soderstrom; H Link
Journal:  Clin Exp Immunol       Date:  2002-03       Impact factor: 4.330

3.  Dendritic cell transmigration through brain microvessel endothelium is regulated by MIP-1alpha chemokine and matrix metalloproteinases.

Authors:  Alla L Zozulya; Emily Reinke; Dana C Baiu; Jozsef Karman; Matyas Sandor; Zsuzsanna Fabry
Journal:  J Immunol       Date:  2007-01-01       Impact factor: 5.422

Review 4.  Immune problems in central nervous system cell therapy.

Authors:  Roger A Barker; Håkan Widner
Journal:  NeuroRx       Date:  2004-10

Review 5.  Dendritic Cells as an Alternate Approach for Treatment of Neurodegenerative Disorders.

Authors:  Veronika Brezovakova; Bernadeta Valachova; Jozef Hanes; Michal Novak; Santosh Jadhav
Journal:  Cell Mol Neurobiol       Date:  2018-06-13       Impact factor: 5.046

Review 6.  Immune cell modulation of oligodendrocyte lineage cells.

Authors:  Emily P Harrington; Dwight E Bergles; Peter A Calabresi
Journal:  Neurosci Lett       Date:  2019-11-03       Impact factor: 3.046

Review 7.  The role of antigen presenting cells in multiple sclerosis.

Authors:  Emily M L Chastain; D'Anne S Duncan; Jane M Rodgers; Stephen D Miller
Journal:  Biochim Biophys Acta       Date:  2010-07-15

8.  Intracerebral dendritic cells critically modulate encephalitogenic versus regulatory immune responses in the CNS.

Authors:  Alla L Zozulya; Sonja Ortler; JangEun Lee; Christian Weidenfeller; Matyas Sandor; Heinz Wiendl; Zsuzsanna Fabry
Journal:  J Neurosci       Date:  2009-01-07       Impact factor: 6.167

Review 9.  Cytokine control of inflammation and repair in the pathology of multiple sclerosis.

Authors:  Jane M Rodgers; Stephen D Miller
Journal:  Yale J Biol Med       Date:  2012-12-13

10.  Effects of low dose GM-CSF on microglial inflammatory profiles to diverse pathogen-associated molecular patterns (PAMPs).

Authors:  Nilufer Esen; Tammy Kielian
Journal:  J Neuroinflammation       Date:  2007-03-20       Impact factor: 8.322

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.